MyAverix Finance
HK · Healthcare
Ascletis Pharma Inc (1672)
Biotechnology
Ascletis Pharma Inc (1672) is listed on HK in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported market cap is $16.19B, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 1672
Ascletis Pharma Inc (1672) — FAQ
What is Ascletis Pharma Inc's market cap?
Ascletis Pharma Inc (1672) has a reported market cap of $16.19B (data as of 2026-05-21).
What is 1672's P/E ratio?
The price-to-earnings (P/E) ratio for Ascletis Pharma Inc (1672) is 18.00 (data as of 2026-05-21).
Does Ascletis Pharma Inc pay a dividend?
Dividend yield is not available in the current snapshot for Ascletis Pharma Inc (1672). Check the MyAverix Finance app for the latest dividend data.
What sector is Ascletis Pharma Inc in?
Ascletis Pharma Inc (1672) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 1672 listed on?
1672 is listed on HK.
What is Ascletis Pharma Inc's net margin?
Ascletis Pharma Inc (1672) reports a net margin of 0.0% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.